Search Results 641-650 of 17039 for pharmacogenetics
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Ivosidenib and pemigatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving gemcitabine and cisplatin with ...
This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...
About this study. The aim of the clinical trial is evaluate the EndoRotor®'s ability to completely remove areas of Barrett's metaplasia considered ...
About this study. The purpose of this study is to characterize a landscape of DNA alterations, RNA transcripts, and microbiome changes in resected tumors ...
Wangensteen L, Mohamed F, Oberhelman-Eaton SS, Averkamp NM, Kiernan JA, Selladurai RI, Bohn BA, Lai B, O'Grady J. A Strategy to Improve Hepatitis B Vaccine ...
About this study. The purpose of this study is to test if a rare variant in the osteocalcin protein may act as a gain of function mutation in this molecule.
Study PT-112-102, a multicenter, open-label dose-finding and pharmacokinetic study of PT-112 in patients with relapsed or refractory multiple myeloma. This is ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.